Botanical species · safety record

Fagopyrum esculentum

The EFSA Compendium of Botanicals holds 2 constituent measurements and 1 adverse-effect record for Fagopyrum esculentum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fagopyrum esculentum Moench

2Constituent measurements
1Safety records
2Cited sources
115Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 115 licensed products naming Fagopyrum esculentum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Fagopyrum esculentum
  • Fagopyrum esculentum - seed
  • Fagopyrum esculentum - whole plant
  • Graine
  • Leaf
  • New material
  • Seed
  • Seed(s)

What the records describe

Constituents measured

  • Fagopyrin2

Plant parts

  • Aerial part of plants3

Preparations

  • Solvent extraction3

Effect types

  • Other toxicities1

Target tissues

  • Skin1
  • subcutis1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
FagopyrinAerial part of plantsSolvent extraction≥ 322 Microgram/gramHPLC-FDResolve DOI
FagopyrinAerial part of plantsSolvent extraction≤ 4840 Microgram/gramHPLC-FDResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Other toxicitiesSkin/subcutisAerial part of plantsSolvent extractionIn vitroNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hinneburg, I., Kempe, S., Ruettinger, H.-H., Neubert, R. H. H. A CE method for measuring phototoxicity in vitro. Chromatographia, 2005, p. 325-329.
  2. Stojilkovski, Katja., Glavac, Nina Kocevar., Kreft, Samo., Kreft, Ivan. Fagopyrin and flavonoid contents in common, Tartary, and cymosum buckwheat. JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2013, vol. 32, no. 2, p. 126-130. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue